Monoamine Oxidase (MAO) Is Expressed at the Level of Mitral Valve with Severe Regurgitation in Hypertrophic Obstructive Cardiomyopathy: A Case Report

Monoamine Oxidase (MAO) Is Expressed at the Level of Mitral Valve with Severe Regurgitation in Hypertrophic Obstructive Cardiomyopathy: A Case Report

Hypertrophic obstructive cardiomyopathy (HOCM) is one of the most common hereditary heart diseases. The severely hypertrophied interventricular septum combined with the systolic anterior movement (SAM) of the mitral valve (MV) frequently cause a significant pressure gradient in the left ventricular...

Full description

Bibliographic Details
Main Authors:	Ana Lascu, Raluca Șoșdean, Loredana Nicoleta Ionică, Alexandru S. Pescariu, Lucian Petrescu, Adina Ionac, Constantin T. Luca, Adrian Sturza, Horea B. Feier
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Medicina
Subjects:	hypertrophic obstructive cardiomyopathy mitral valve regurgitation monoamine oxidase oxidative stress MAO inhibitors
Online Access:	https://www.mdpi.com/1648-9144/58/12/1844

Similar Items

β-Carboline Alkaloids in Soy Sauce and Inhibition of Monoamine Oxidase (MAO)
by: Tomás Herraiz
Published: (2023-03-01)

Prognostic Value of Mitral Regurgitation in Patients with Primary Hypertrophic Cardiomyopathy
by: Milorad Tesic, et al.
Published: (2023-10-01)

An investigation of the monoamine oxidase inhibition properties of benzothiazole derivatives
by: Anandie le Roux, et al.
Published: (2025-03-01)

Catalysis & inhibition issues associated with Monoamine Oxidase (MAO). How unusually low α-C-H bond dissociation energies may open the door to single electron transfer
by: Jonathan Sánchez González, et al.
Published: (2023-12-01)

Monoamine oxidase inhibition in cigarette smokers: From preclinical studies to tobacco product regulation
by: Alan F. Sved, et al.
Published: (2022-08-01)

Synthesis of 1,2,4-Oxadiazin-5(6<i>H</i>)-One Derivatives and Their Biological Investigation as Monoamine Oxidase Inhibitors
by: Sofia I. Presnukhina, et al.
Published: (2024-11-01)

Impact of standard of care medication on valvular oxidative stress in patients with severe mitral regurgitation
by: Raluca Sosdean, et al.
Published: (2024-11-01)

Development and Clinical Application of Positron Emission Tomography Imaging Agents for Monoamine Oxidase B
by: Jeffrey H. Meyer, et al.
Published: (2022-02-01)

Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012–2024)
by: Iyman Alsaad, et al.
Published: (2024-12-01)

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
by: Narayan D. Chaurasiya, et al.
Published: (2022-07-01)

Synthesis and Monoamine Oxidase Inhibition Properties of 4-(2-Methyloxazol-4-yl)benzenesulfonamide
by: Anton A. Shetnev, et al.
Published: (2024-03-01)

Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca
by: Ilana Berlowitz, et al.
Published: (2022-05-01)

Anesthesia management in patient with nonobstructive hypertrophic cardiomyopathy with severe mitral valvular regurgitation with severe pulmonary artery hypertension for mitral valve replacement: Its “walk a tight rope”
by: Nikhil N Mudgalkar
Published: (2021-01-01)

Harmane Potentiates Nicotine Reinforcement Through MAO-A Inhibition at the Dose Related to Cigarette Smoking
by: Zheng Ding, et al.
Published: (2022-06-01)

The use of MitraClip for nonobstructive hypertrophic cardiomyopathy with mixed severe mitral valve regurgitation
by: Jie Zeng, et al.
Published: (2023-04-01)

Ageing and Neurodegeneration – The Role of Neurotransmitters’ Activity
by: Bonka Lozanska, et al.
Published: (2022-12-01)

Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR
by: Aakash N. Gupta, et al.
Published: (2021-12-01)

Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
by: Reem Aljanabi, et al.
Published: (2021-10-01)

Research progress of non-monoamine antidepressants
by: Huan Zhang, et al.
Published: (2021-12-01)

Inhibitory effects of agmatine on monoamine oxidase (MAO) activity: Reconciling the discrepancies
by: Mancinelli Loretta, et al.
Published: (2018-04-01)

Different mechanisms of mitral regurgitation in hypertrophic cardiomyopathy: A clinical case and literature review
by: Michela Molisana, et al.
Published: (2022-10-01)

Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis
by: Andy Wai Kan Yeung, et al.
Published: (2019-05-01)

Discovery of N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B
by: Ahmed Elkamhawy, et al.
Published: (2020-01-01)

Reconstructive surgery of idiopathic hypertrophic cardiomyopathy, systolic anterior motion and severe mitral regurgitation
by: Stojanović Ivan, et al.
Published: (2004-01-01)

Myectomy with and without Mitral Subvalvular Repair in Patients with Hypertrophic Obstructive Cardiomyopathy with Grade 3 to 4+ Mitral Regurgitation without Intrinsic Mitral Valve Disease: A Retrospective Observational Study
by: Fangyu Liu, et al.
Published: (2022-08-01)

Meta-analysis examining the association between low platelet monoamine oxidase levels and Zuckerman's sensation seeking scale in a sex dependent manner
by: Jordan Winfield, et al.
Published: (2025-02-01)

Prognostic Implication of Mitral Valve Disease and Its Progression in East Asian Patients With Hypertrophic Cardiomyopathy
by: Dae‐Young Kim, et al.
Published: (2023-02-01)

Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A
by: Muhammad Rafehi, et al.
Published: (2019-10-01)

The Discrediting of the Monoamine Hypothesis [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

STUDY MOLECULES DOCKING OF ALKALOIDS IN KRATOM ON SEROTONIN TRANSPORTER (SERT), NOREPINEPHRINE TRANSPORTER (NET), AND MONOAMINE OXIDASE (MAO)
by: Dandi Irawan, et al.
Published: (2023-12-01)

Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation
by: Dong Wang, et al.
Published: (2019-11-01)

Monoamine oxidases contribute to endothelial dysfunction of the vascular access in hemodialysis patients
by: Diana Utu, et al.
Published: (2016-12-01)

Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors
by: Sanna Rauhamäki, et al.
Published: (2018-03-01)

Comparison of monoamine oxidase and selected heavy metal levels in the blood and the workplace among e-waste sorting workers in Ubon Ratchathani Province, Thailand
by: Kornwika Harasarn, et al.
Published: (2022-12-01)

Inhibition of monoamine oxidases by benzimidazole chalcone derivatives
by: Athulya Krishna, et al.
Published: (2023-06-01)

The Discrediting of the Monoamine Hypothesis [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Cigarette Smoke Extract, but Not Electronic Cigarette Aerosol Extract, Inhibits Monoamine Oxidase in vitro and Produces Greater Acute Aversive/Anhedonic Effects Than Nicotine Alone on Intracranial Self-Stimulation in Rats
by: Andrew C. Harris, et al.
Published: (2022-05-01)

Yeni şalkon türevlerinin monoamin oksidaz enzim inhibitör aktivitelerinin araştırılması
by: Nafiz Öncü CAN
Published: (2018-06-01)

Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress
by: Mohamed H. Elsherbeny, et al.
Published: (2021-10-01)

Exercise Benefits Brain Function: The Monoamine Connection
by: Tzu-Wei Lin, et al.
Published: (2013-01-01)